Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ultralight Labs
AddedFeb 17, 2024
UpdatedJun 18, 2026
Ultralight Labs

Ultralight Labs

Seed

NYC-based Ultralight Labs accelerates medical device innovation with a streamlined, compliance-focused software platform.

HQ
New York City, NY, US
Founded
2022
Overview
Compare
Fundraising
Employees
Website

Founded in New York City, Ultralight Labs accelerates medical device innovation by providing a streamlined software platform focused on compliance and operational efficiency. Their core mission is to simplify the complex and time-consuming aspects of medical device development, offering a lightweight solution for requirements and risk management, end-to-end traceability, and related compliance activities. This platform is optimized for the fast-paced nature of modern device development, targeting medtech companies looking to enhance their product development workflows.

Notable affiliated people and investors include key figures in the medical technology and software development sectors, although specific names are not publicly disclosed. Ultralight Labs has achieved significant milestones in improving the efficiency of medical device development processes, earning recognition for their innovative approach to compliance and operational streamlining. Their impact is evident in the accelerated timelines and reduced complexities experienced by their clients, positioning Ultralight Labs as a crucial player in the medtech industry.

Ultralight Labs - Similar Companies

uLink Labs logo

uLink Labs

ulink-labs.com

Nemedio logo

Nemedio

nemedio.com

Essenvia logo

Essenvia

essenvia.com

Ketryx logo

Ketryx

ketryx.com

UptimeHealth logo

UptimeHealth

uptimehealth.com

QuickComply logo

QuickComply

appmaster.io

Kompliant logo

Kompliant

kompliant.com

Sierra Labs logo

Sierra Labs

sierralabs.com

Team Labs logo

Team Labs

teamlabs.io

Menlo Park Software logo

Menlo Park Software

RigPlenish logo

RigPlenish

Clearpol logo

Clearpol

clearpol.com

Untether Labs logo

Untether Labs

untetherlabs.com

Greenlight Guru logo

Greenlight Guru

greenlight.guru

Simplifya logo

Simplifya

simplifya.com

Ultralight Labs - Quick Facts

Who are Ultralight Labs' competitors?

Companies similar to Ultralight Labs include uLink Labs, Nemedio, Essenvia and Ketryx.

When was Ultralight Labs founded?

Ultralight Labs was founded in 2022.

Where is Ultralight Labs' headquarters located?

Ultralight Labs' headquarters is located in New York City, NY, US.

When was Ultralight Labs' last funding round?

Ultralight Labs' most recent funding round was for $2.7M (USD) in July 2023.

How much has Ultralight Labs raised to-date?

As of Jul 21, 2023, Ultralight Labs has raised a total of $2.7M (USD).

How many employees does Ultralight Labs have?

Ultralight Labs has 6 employees as of Feb 5, 2024.

Ultralight Labs - Classification

Ownership
  • Venture Capital
Technology
  • SaaS
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Compliance
  • Software
Tags
  • Healthtech
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7372Prepackaged Software
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified